Interestingly, Homozygous patients with the UGT1A1*28 allele were found to have a heightened susceptibility to neutropenia when administered SG, as indicated by a higher incidence of all-grade neutropenia compared to heterozygous or wild-type individuals. This evidence concerns the gene UGT1A1 and Decreased total neutrophil count.